Drug Shortage Report for BEXSERO
| Report ID | 55706 |
| Drug Identification Number | 02417030 |
| Brand name | BEXSERO |
| Common or Proper name | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Recombinant Neisseria meningitidis group B NHBA fusion protein Recombinant Neisseria meningitidis group B NadA protein Recombinant Neisseria meningitidis group B fHBP fusion protein Outer membrane vesicles |
| Strength(s) | 50MCG 50MCG 50MCG 25MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07AH |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-07-10 |
| Estimated end date | 2018-08-24 |
| Actual end date | 2018-08-07 |
| Shortage status | Resolved |
| Updated date | 2018-08-08 |
| Company comments | Supply in pack size of 1’s is unavailable in the private market. BEXSERO is available in packages of 10. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-08-08 | French | Compare |
| v5 | 2018-08-08 | English | Compare |
| v4 | 2018-07-18 | French | Compare |
| v3 | 2018-07-18 | English | Compare |
| v2 | 2018-07-13 | French | Compare |
| v1 | 2018-07-13 | English | Compare |
Showing 1 to 6 of 6